Results 151 to 160 of about 3,867 (204)
The action of piracetam in ischaemic flaps
The effects of piracetam on skin flap viability, capillary blood flow and temperature were studied in abdominal cutaneous flaps in rats. The drug significantly increased the viability of the distal (random) portion of the flap and this response was dose-related.
D, Rossillon +4 more
openaire +3 more sources
Piracetam improves mitochondrial dysfunction following oxidative stress
1.--Mitochondrial dysfunction including decrease of mitochondrial membrane potential and reduced ATP production represents a common final pathway of many conditions associated with oxidative stress, for example, hypoxia, hypoglycemia, and aging.
Anne Eckert +2 more
exaly +2 more sources
Piracetam treatment in patients with cognitive impairment
Piracetam is a cognitive-enhancing agent that is used for the treatment of cognitive impairments of various etiologies. Little is known about its side effect profile, especially in those with psychiatric illness.
Ganesan Venkatasubramanian +2 more
exaly +2 more sources
Treatment of Acute Ischemic Stroke With Piracetam
Background and Purpose Piracetam, a nootropic agent with neuroprotective properties, has been reported in pilot studies to increase compromised regional cerebral blood flow in patients with acute stroke and, given soon after ...
Peter Paul De Deyn +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Antimyoclonic Action of Piracetam
Clinical Neuropharmacology, 1986Five patients with myoclonus were treated with oral piracetam (8-9 g/day). All patients had action-sensitive and/or stimulus-sensitive myoclonus and enhanced amplitude of somatosensory evoked potentials. Piracetam produced a marked reduction of the myoclonus in the five subjects without side effects.
J A, Obeso +4 more
openaire +2 more sources
Piracetam in Elderly Motorists
Pharmacopsychiatry, 1991101 elderly motorists with reduced reaction capacity were examined under real traffic conditions with regard to their driving ability. They were given a daily dose of 4.8 g piracetam or placebo over a six-week period in a randomised double-blind study.
U, Schmidt +4 more
openaire +2 more sources
Piracetam and Piracetam-Like Drugs
Drugs, 2010There is an increasing interest in nootropic drugs for the treatment of CNS disorders. Since the last meta-analysis of the clinical efficacy of piracetam, more information has accumulated. The primary objective of this systematic survey is to evaluate the clinical outcomes as well as the scientific literature relating to the pharmacology ...
Andrei G, Malykh, M Reza, Sadaie
openaire +2 more sources
Journal of Clinical Psychopharmacology, 1987
Previous research has suggested that dyslexics treated with piracetam have shown improvements in reading skills, verbal memory and verbal conceptualizing ability, feature analysis, and processing of letter-like stimuli. Two hundred twenty-five dyslexic children between the ages of 7 years 6 months and 12 years 11 months whose reading skills were ...
COLIN R. WILSHER +12 more
openaire +1 more source
Previous research has suggested that dyslexics treated with piracetam have shown improvements in reading skills, verbal memory and verbal conceptualizing ability, feature analysis, and processing of letter-like stimuli. Two hundred twenty-five dyslexic children between the ages of 7 years 6 months and 12 years 11 months whose reading skills were ...
COLIN R. WILSHER +12 more
openaire +1 more source
Effect of Piracetam in Huntington’s Chorea
European Neurology, 2008Piracetam has been described to improve neuroleptic-induced acute extrapyramidal syndrome where a central dopaminergic hyperactivity is implicated. In Huntington’s chorea, this abnormality is also generally admitted, at least functionally. Therefore the authors have utilized piracetam in this disease. The drug was administered intravenously in a double-
A, Destée, H, Petit, P, Warot
openaire +2 more sources

